@article{76f68bf4e020446789b08fb6546d22be,
title = "The assessment of future RSV immunizations: How to protect all infants?",
keywords = "infant and child health, infant hospitalization, infant immunization, infant mortality, monoclonal antibody, respiratory disease, respiratory syncytial virus (RSV), RSV-acute lower respiratory illness",
author = "Louis Bont and {Weil Olivier}, Catherine and Egbert Herting and Susanna Esposito and {Navarro Alonso}, {Jose Antonio} and Federico Lega and Silke Mader and Ichiro Morioka and Kunling Shen and Syrogiannopoulos, {George A.} and Faust, {Saul N.} and Elena Bozzola",
note = "Funding Information: Sanofi and AstraZeneca facilitated and financially supported the RSV Experts Group Event, remuneration to some of the experts was agreed for the time spent for the meeting but the authors were not paid for writing the publication. Funding for the publication fees was provided by Sanofi and AstraZeneca. Hyderus CYF—was paid by Sanofi and AstraZeneca for the expert meeting organization, medical writing, and editorial support. ",
year = "2022",
month = aug,
day = "9",
doi = "10.3389/fped.2022.981741",
language = "English",
volume = "10",
pages = "981741",
journal = "Frontiers in Pediatrics",
issn = "2296-2360",
publisher = "Frontiers Media SA",
}